Back to VRCA

Affinity Asset Advisors, LLC → VRCA

Affinity Asset Advisors, LLC VRCA Position History

Verrica Pharmaceuticals Inc. • Healthcare

Quarters held
4
Latest value
$3.3M
Q3 2026
Peak value
$5.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$5.9M
Q1 2026$3.7M
Q2 2026$4.3M
Q3 2026$3.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$3.3M688.7K——
Q2 2026$4.3M707.3K——
Q1 2026$3.7M707.3K——
Q4 2025$5.9M707.3K——

Other funds holding VRCA

Other Affinity Asset Advisors, LLC positions

ROIV

ROIVANT SCIENCES LTD

$132.7M
APGE

APOGEE THERAPEUTICS INC

$131M
ROIV

ROIVANT SCIENCES LTD

$117M
SYRE

SPYRE THERAPEUTICS INC

$113.9M
SYRE

SPYRE THERAPEUTICS INC

$113.6M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M